Karasawa R, Yudoh K, Sato T, Tanaka M, Sabbagh S, Flegel W
Rheumatology (Oxford). 2023; 62(11):3757-3762.
PMID: 37144941
PMC: 10629777.
DOI: 10.1093/rheumatology/kead203.
Rathore U, Nigam N, Aggarwal A, Gupta L
Mediterr J Rheumatol. 2022; 33(3):380-382.
PMID: 36531418
PMC: 9727465.
DOI: 10.31138/mjr.33.3.380.
Vagha K, Venkata Sai Akhil C, Madirala S, Varma A, Lakra M, Vagha J
BMC Pediatr. 2022; 22(1):623.
PMID: 36316673
PMC: 9620603.
DOI: 10.1186/s12887-022-03704-5.
Mondal S, Barman P, Vignesh P
Front Med (Lausanne). 2022; 9:827539.
PMID: 35814777
PMC: 9263083.
DOI: 10.3389/fmed.2022.827539.
Karasawa R, Yudoh K, Sato T, Tanaka M, Tamaki M, Sabbagh S
Rheumatology (Oxford). 2021; 61(7):2969-2977.
PMID: 34791087
PMC: 9258543.
DOI: 10.1093/rheumatology/keab846.
Expression of interferon-regulated genes in juvenile dermatomyositis versus Mendelian autoinflammatory interferonopathies.
Kim H, Gunter-Rahman F, McGrath J, Lee E, de Jesus A, Targoff I
Arthritis Res Ther. 2020; 22(1):69.
PMID: 32252809
PMC: 7137415.
DOI: 10.1186/s13075-020-02160-9.
Co-expression network analysis reveals the pivotal role of mitochondrial dysfunction and interferon signature in juvenile dermatomyositis.
Zhong D, Wu C, Bai J, Xu D, Zeng X, Wang Q
PeerJ. 2020; 8:e8611.
PMID: 32110496
PMC: 7034382.
DOI: 10.7717/peerj.8611.
Unusual cause for intestinal perforation in juvenile dermatomyositis.
Bhaskaran H, Balan S
BMJ Case Rep. 2019; 12(8).
PMID: 31444261
PMC: 6721139.
DOI: 10.1136/bcr-2019-229395.
Plasma exosomes from children with juvenile dermatomyositis are taken up by human aortic endothelial cells and are associated with altered gene expression in those cells.
Jiang K, Karasawa R, Hu Z, Chen Y, Holmes L, ONeil K
Pediatr Rheumatol Online J. 2019; 17(1):41.
PMID: 31299993
PMC: 6626431.
DOI: 10.1186/s12969-019-0347-0.
Systemic and Tissue Inflammation in Juvenile Dermatomyositis: From Pathogenesis to the Quest for Monitoring Tools.
Wienke J, Deakin C, Wedderburn L, van Wijk F, Royen-Kerkhof A
Front Immunol. 2019; 9:2951.
PMID: 30619311
PMC: 6305419.
DOI: 10.3389/fimmu.2018.02951.
The Vasculopathy of Juvenile Dermatomyositis.
Papadopoulou C, McCann L
Front Pediatr. 2018; 6:284.
PMID: 30356795
PMC: 6189418.
DOI: 10.3389/fped.2018.00284.
Development of practice and consensus-based strategies including a treat-to-target approach for the management of moderate and severe juvenile dermatomyositis in Germany and Austria.
Hinze C, Oommen P, Dressler F, Urban A, Weller-Heinemann F, Speth F
Pediatr Rheumatol Online J. 2018; 16(1):40.
PMID: 29940960
PMC: 6019723.
DOI: 10.1186/s12969-018-0257-6.
Multiple target autoantigens on endothelial cells identified in juvenile dermatomyositis using proteomics.
Karasawa R, Tamaki M, Sato T, Tanaka M, Nawa M, Yudoh K
Rheumatology (Oxford). 2018; 57(4):671-676.
PMID: 29361142
PMC: 5888918.
DOI: 10.1093/rheumatology/kex468.
Biologic therapies for refractory juvenile dermatomyositis: five years of experience of the Childhood Arthritis and Rheumatology Research Alliance in North America.
Spencer C, Rouster-Stevens K, Gewanter H, Syverson G, Modica R, Schmidt K
Pediatr Rheumatol Online J. 2017; 15(1):50.
PMID: 28610606
PMC: 5470177.
DOI: 10.1186/s12969-017-0174-0.
Treatment of Juvenile Dermatomyositis: An Update.
Papadopoulou C, Wedderburn L
Paediatr Drugs. 2017; 19(5):423-434.
PMID: 28550457
DOI: 10.1007/s40272-017-0240-6.
Connective Tissue Disorder-Associated Vasculitis.
Sharma A, Dhooria A, Aggarwal A, Rathi M, Chandran V
Curr Rheumatol Rep. 2016; 18(6):31.
PMID: 27097818
DOI: 10.1007/s11926-016-0584-x.
Idiopathic Inflammatory Myopathies: an Update on Classification and Treatment with Special Focus on Juvenile Forms.
Pagnini I, Vitale A, Selmi C, Cimaz R, Cantarini L
Clin Rev Allergy Immunol. 2015; 52(1):34-44.
PMID: 26429707
DOI: 10.1007/s12016-015-8512-9.
Acute acalculous cholecystitis in a patient with juvenile dermatomyositis.
Sanches B, Martins T, Santos M, Azeredo P
BMJ Case Rep. 2014; 2014.
PMID: 25239990
PMC: 4170240.
DOI: 10.1136/bcr-2014-205066.
Gender and ocular manifestations of connective tissue diseases and systemic vasculitides.
Choudhary M, Hajj-Ali R, Lowder C
J Ophthalmol. 2014; 2014:403042.
PMID: 24757559
PMC: 3976932.
DOI: 10.1155/2014/403042.
Validation of a score tool for measurement of histological severity in juvenile dermatomyositis and association with clinical severity of disease.
Varsani H, Charman S, Li C, Marie S, Amato A, Banwell B
Ann Rheum Dis. 2013; 74(1):204-10.
PMID: 24064003
PMC: 4283618.
DOI: 10.1136/annrheumdis-2013-203396.